文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

间歇性低氧与 2 型糖尿病和阻塞性睡眠呼吸暂停低通气综合征中的肠道微生物失调有关。

Intermittent hypoxia is involved in gut microbial dysbiosis in type 2 diabetes mellitus and obstructive sleep apnea-hypopnea syndrome.

机构信息

Department of Endocrinology, Henan Provincial Key Medicine Laboratory of Intestinal Microecology and Diabetes, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou 450003, Henan Province, China.

出版信息

World J Gastroenterol. 2022 Jun 7;28(21):2320-2333. doi: 10.3748/wjg.v28.i21.2320.


DOI:10.3748/wjg.v28.i21.2320
PMID:35800187
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9185213/
Abstract

BACKGROUND: Obstructive sleep apnea (OSA)-hypopnea syndrome (OSAHS) has been recognized as a comorbidity of type 2 diabetes mellitus (T2DM); more than half of T2DM patients suffer from OSAHS. Intermittent hypoxia (IH) plays an important role in metabolic diseases, such as obesity and OSAHS, through various mechanisms, including altering the gut microecological composition and function. Therefore, it is important to study the role of gut microbiota in T2DM patients with OSAHS, which has a high incidence and is prone to several complications. AIM: To assess whether IH is involved in altering the fecal microbiome in T2DM patients with OSAHS. METHODS: Seventy-eight participants were enrolled from Henan Province People's Hospital and divided into healthy control (HC, = 26), T2DM ( = 25), and T2DM + OSA ( = 27) groups based on their conditions. The fecal bacterial DNA of the research participants was extracted and subjected to 16S ribosomal RNA sequencing. The clinical indices, such as insulin resistance index, homocysteine (HCY) concentration, and the concentrations of inflammatory factors in the peripheral blood, were assessed and recorded. RESULTS: Group T2DM + OSA had the highest apnea-hypopnea index (AHI) (2.3 3.7 13.7), oxygen desaturation index (0.65 2.2 9.1), HCY concentration (9.6 μmol/L 10.3 μmol/L 13.81 μmol/L) and C-reactive protein (CRP) concentrations (0.3 mg/L 1.43 mg/L 2.11 mg/L), and lowest mean oxygen saturation (97.05% 96.6% 94.7%) among the three groups. Twelve and fifteen key differences in amplicon sequence variants were identified when comparing group T2DM + OSA with groups T2DM and HC, respectively. We found progressively decreased levels of , and and an increase in the level of which strongly correlated with the HCY, CRP, fasting plasma glucose, and hemoglobin A1c concentrations, AHI, mean oxygen saturation, and insulin resistance index in group T2DM + OSA ( < 0.05). CONCLUSION: For T2DM patients with OSAHS, IH may be involved in selective alterations of the gut microbiota, which may affect the pathophysiological development of T2DM and DM-related complications.

摘要

背景:阻塞性睡眠呼吸暂停低通气综合征(OSAHS)已被认为是 2 型糖尿病(T2DM)的合并症之一;超过一半的 T2DM 患者患有 OSAHS。间歇性低氧(IH)通过改变肠道微生物群落组成和功能等多种机制,在肥胖和 OSAHS 等代谢性疾病中发挥重要作用。因此,研究 OSAHS 伴 2 型糖尿病患者肠道微生物群的作用非常重要,因为 OSAHS 发病率高,且易发生多种并发症。

目的:评估间歇性低氧是否参与改变 OSAHS 伴 2 型糖尿病患者的粪便微生物群。

方法:本研究共招募了 78 名来自河南省人民医院的参与者,根据他们的病情分为健康对照组(HC,n=26)、T2DM 组(n=25)和 T2DM+OSA 组(n=27)。提取研究参与者的粪便细菌 DNA,并进行 16S 核糖体 RNA 测序。评估并记录临床指标,如胰岛素抵抗指数、同型半胱氨酸(HCY)浓度和外周血中炎症因子的浓度。

结果:T2DM+OSA 组的呼吸暂停低通气指数(AHI)最高(2.3 3.7 13.7),氧减指数(0.65 2.2 9.1)、HCY 浓度(9.6 μmol/L 10.3 μmol/L 13.81 μmol/L)和 C 反应蛋白(CRP)浓度(0.3 mg/L 1.43 mg/L 2.11 mg/L)最高,三组中最低的平均氧饱和度为 97.05%、96.6%和 94.7%。与 T2DM 组和 HC 组相比,T2DM+OSA 组分别有 12 个和 15 个扩增子序列变异的关键差异。我们发现,随着 T2DM+OSA 组 HCY、CRP、空腹血糖和糖化血红蛋白浓度、AHI、平均氧饱和度和胰岛素抵抗指数的增加, 、 、 和 水平逐渐降低, 水平升高(<0.05)。

结论:对于 OSAHS 伴 2 型糖尿病患者,IH 可能参与了肠道微生物群的选择性改变,这可能影响 2 型糖尿病及其相关并发症的病理生理发展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b76c/9185213/57e76c35ca68/WJG-28-2320-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b76c/9185213/c9177509b40a/WJG-28-2320-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b76c/9185213/cfc73fbeaf9e/WJG-28-2320-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b76c/9185213/fc60d439c2b1/WJG-28-2320-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b76c/9185213/05cd505a1647/WJG-28-2320-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b76c/9185213/7d2094cfa300/WJG-28-2320-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b76c/9185213/57e76c35ca68/WJG-28-2320-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b76c/9185213/c9177509b40a/WJG-28-2320-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b76c/9185213/cfc73fbeaf9e/WJG-28-2320-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b76c/9185213/fc60d439c2b1/WJG-28-2320-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b76c/9185213/05cd505a1647/WJG-28-2320-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b76c/9185213/7d2094cfa300/WJG-28-2320-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b76c/9185213/57e76c35ca68/WJG-28-2320-g006.jpg

相似文献

[1]
Intermittent hypoxia is involved in gut microbial dysbiosis in type 2 diabetes mellitus and obstructive sleep apnea-hypopnea syndrome.

World J Gastroenterol. 2022-6-7

[2]
Gut microbiota in obstructive sleep apnea-hypopnea syndrome: disease-related dysbiosis and metabolic comorbidities.

Clin Sci (Lond). 2019-4-12

[3]
Disruption of sleep architecture in Prevotella enterotype of patients with obstructive sleep apnea-hypopnea syndrome.

Brain Behav. 2019-4-8

[4]
[Effect of CPAP therapy on dynamic glucose level in OSAHS patients with newly diagnosed T2DM].

Zhonghua Yi Xue Za Zhi. 2015-11-24

[5]
Clinical efficacy and metabolomics study of Wendan Decoction in the treatment of phlegm-dampness obstructive sleep apnea-hypopnea syndrome with type 2 diabetes mellitus.

J Ethnopharmacol. 2023-12-5

[6]
Association of diabetic nephropathy with the severity of obstructive sleep apnea-hypopnea syndrome in patients with type 2 diabetes mellitus.

Endocr J. 2020-5-28

[7]
Gut microbiota dysbiosis in 4- to 6-year-old children with obstructive sleep apnea-hypopnea syndrome.

Pediatr Pulmonol. 2022-9

[8]
Research on the Association Between Obstructive Sleep Apnea Hypopnea Syndrome Complicated With Coronary Heart Disease and Inflammatory Factors, Glycolipid Metabolism, Obesity, and Insulin Resistance.

Front Endocrinol (Lausanne). 2022

[9]
[The effect of chronic intermittent hypoxia caused by obstructive sleep apnea hypopnea syndrome on blood pressure].

Zhonghua Jie He He Hu Xi Za Zhi. 2007-12

[10]
[Factors influencing glucose metabolism in young obese subjects with obstructive sleep apnea hypopnea syndrome].

Zhonghua Yi Xue Za Zhi. 2016-5-17

引用本文的文献

[1]
The mediating role of BMI in the relationship between OSAHS and bone metabolism in male patients with T2DM.

Sleep Breath. 2025-4-12

[2]
Obstructive sleep apnoea as a neuromuscular respiratory disease arising from an excess of central GABAergic neurotransmitters: a new disease model.

Front Cell Neurosci. 2025-1-6

[3]
Exploring the pharmacological mechanisms for alleviating OSA: Adenosine A2A receptor downregulation of the PI3K/Akt/HIF‑1 pathway (Review).

Biomed Rep. 2024-11-28

[4]
Causal relationships between gut microbiome and obstructive sleep apnea: a bi-directional Mendelian randomization.

Front Microbiol. 2024-8-23

[5]
Polycystic ovary syndrome in obstructive sleep apnea-hypopnea syndrome: an updated meta-analysis.

Front Endocrinol (Lausanne). 2024

[6]
Association of Obstructive Sleep Apnea with Nonalcoholic Fatty Liver Disease: Evidence, Mechanism, and Treatment.

Nat Sci Sleep. 2024-7-8

[7]
Uncovering the mechanism of CBX 2021 to improve pig health based on and studies.

Front Microbiol. 2024-6-14

[8]
Association between elevated homocysteine levels and obstructive sleep apnea hypopnea syndrome: a systematic review and updated meta-analysis.

Front Endocrinol (Lausanne). 2024

[9]
Fibromyalgia in obstructive sleep apnea-hypopnea syndrome: a systematic review and meta-analysis.

Front Physiol. 2024-5-20

[10]
Assessing the causal association between sleep apnea and the human gut microbiome composition: A two-sample Mendelian randomization study.

SAGE Open Med. 2024-5-6

本文引用的文献

[1]
Role of gut microbiota in the development of insulin resistance and the mechanism underlying polycystic ovary syndrome: a review.

J Ovarian Res. 2020-6-17

[2]
The Gut-Lung Axis in Health and Respiratory Diseases: A Place for Inter-Organ and Inter-Kingdom Crosstalks.

Front Cell Infect Microbiol. 2020

[3]
The characterization of lung microbiome in lung cancer patients with different clinicopathology.

Am J Cancer Res. 2019-9-1

[4]
Faecalibacterium prausnitzii-derived microbial anti-inflammatory molecule regulates intestinal integrity in diabetes mellitus mice via modulating tight junction protein expression.

J Diabetes. 2019-10-30

[5]
Homocysteine Levels are Associated with Endothelial Function in Newly Diagnosed Type 2 Diabetes Mellitus Patients.

Metab Syndr Relat Disord. 2019-5-2

[6]
Gut microbiota in obstructive sleep apnea-hypopnea syndrome: disease-related dysbiosis and metabolic comorbidities.

Clin Sci (Lond). 2019-4-12

[7]
Risk of Incident Obstructive Sleep Apnea Among Patients With Type 2 Diabetes.

Diabetes Care. 2019-3-12

[8]
Gut microbial metabolites in obesity, NAFLD and T2DM.

Nat Rev Endocrinol. 2019-5

[9]
Bile Acid 7α-Dehydroxylating Gut Bacteria Secrete Antibiotics that Inhibit Clostridium difficile: Role of Secondary Bile Acids.

Cell Chem Biol. 2018-10-25

[10]
Butyrate Producers as Potential Next-Generation Probiotics: Safety Assessment of the Administration of to Healthy Volunteers.

mSystems. 2018-11-6

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索